I. Yamamoto

发表

Taurine modulates induction of cytochrome P450 3A4 mRNA by rifampicin in the HepG2 cell line.

J. Azuma, Kyoko Takahashi, T. Fukuda, 2002, Biochimica et biophysica acta.

Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver.

T. Inaba, J. Azuma, T. Fukuda, 1999, Biochemical and biophysical research communications.

Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR.

J. Azuma, H. Matsuda, A. Sumida, 2000, Biochemical and biophysical research communications.

Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.

Y. Yamamoto, J. Azuma, T. Fukuda, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population.

J. Azuma, T. Fukuda, S. Fukuen, 2002, Pharmacogenetics.

Identification of the novel splicing variants for the hPXR in human livers.

J. Azuma, T. Fukuda, H. Matsuda, 2002, Biochemical and biophysical research communications.

CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10.

J. Azuma, T. Fukuda, I. Yamamoto, 2000, Pharmacogenetics.

Pioglitazone induces plasma platelet activating factor-acetylhydrolase and inhibits platelet activating factor-mediated cytoskeletal reorganization in macrophage.

Y. Fujio, Makiko Maeda, J. Azuma, 2004, Biochimica et biophysica acta.

Association of plasma PAF acetylhydrolase gene polymorphism with IMT of carotid arteries in Japanese type 2 diabetic patients.

J. Azuma, I. Yamamoto, T. Motomura, 2003, Diabetes research and clinical practice.

The effect of Y-25510 injection on the serum levels of some cytokines in healthy adult volunteers

J. Azuma, M. Hisadome, T. Fukuda, 1998, European Journal of Clinical Pharmacology.

Mutations of the peroxisome proliferator-activated receptor γ (PPARγ) gene in a Japanese population : the Pro12Ala mutation in PPARγ2 is associated with lower concentrations of serum total and non-HDL cholesterol

J. Azuma, T. Fukuda, H. Matsuda, 2001, Diabetologia.

Mutations of the peroxisome proliferator-activated receptor gamma (PPAR gamma) gene in a Japanese population : the Pro12Ala mutation in PPAR gamma 2 is associated with lower concentrations of serum total and non-HDL cholesterol.

J. Azuma, T. Fukuda, H. Matsuda, 2001, Diabetologia.

Taurine attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac myocytes.

H. Iwao, J. Azuma, I. Yamamoto, 2000, European journal of pharmacology.

Effect of taurine on angiotensin II-induced hypertrophy of neonatal rat cardiac cells.

J. Azuma, A. Baba, I. Yamamoto, 1997, Journal of cardiovascular pharmacology.

Circadian variation of the urinary 6β-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity

J. Azuma, I. Yamamoto, M. Ohno, 2000, European Journal of Clinical Pharmacology.

Specific determination of urinary 6beta-hydroxycortisol and cortisol by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.

J. Azuma, K. Saiki, I. Yamamoto, 2000, Journal of chromatography. B, Biomedical sciences and applications.

Effects of grapefruit juice on the pharmacokinetics of the calcium channel blockers nifedipine and nisoldipine

J. Azuma, I. Yamamoto, K. Yoshikawa, 1998 .

CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin

J. Azuma, T. Fukuda, A. Sumida, 1999, European Journal of Clinical Pharmacology.

The association of Pro12Ala polymorphism in PPARgamma2 with lower carotid artery IMT in Japanese.

J. Azuma, M. Ohmoto, I. Yamamoto, 2003, Diabetes research and clinical practice.

Adrenergic β1 Receptor Polymorphism (Ser49Gly) Is Associated with Obesity in Type II Diabetic Patients

S. Nonen, Y. Fujio, Makiko Maeda, 2008 .

The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population

J. Azuma, T. Fukuda, I. Yamamoto, 2000, European Journal of Clinical Pharmacology.

Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers.

J. Azuma, T. Fukuda, I. Yamamoto, 1999, British journal of clinical pharmacology.

Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages.

Y. Fujio, Makiko Maeda, J. Azuma, 2003, Biochimica et biophysica acta.

Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteers

J. Azuma, T. Fukuda, I. Yamamoto, 2003, European Journal of Clinical Pharmacology.

Evaluation of Oral Mucoadhesive Microspheres in Man on the Basis of the Pharmacokinetics of Furosemide and Riboflavin, Compounds with Limited Gastrointestinal Absorption Sites

J. Azuma, I. Yamamoto, Y. Ogawa, 1998, The Journal of pharmacy and pharmacology.

MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.

S. Nonen, Y. Fujio, Makiko Maeda, 2008, Journal of diabetes and its complications.

Diabetic Retinopathy Possibly Results From Poor Blood Sugar Control Associated With MTHFR Gene Polymorphism in Type 2 Diabetic Patients Response to Yoshioka et al.

S. Nonen, Y. Fujio, Makiko Maeda, 2003 .

MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation.

S. Nonen, Y. Fujio, Makiko Maeda, 2003, Diabetes care.

Synthesis of a Novel Biotinyl Derivative and its Application to Non-Radioactive Labeling of DNA

T. Mukai, J. Azuma, T. Fukuda, 1997 .

Adrenergic beta1 receptor polymorphism (Ser49Gly) is associated with obesity in type II diabetic patients.

S. Nonen, Y. Fujio, Makiko Maeda, 2008, Biological & pharmaceutical bulletin.

Evaluation of induction of CYP3A mRNA using the HepG2 cell line and reverse transcription-PCR.

A. Sumida, I. Yamamoto, Junichi Azuma, 1999, Biological & pharmaceutical bulletin.